Stock Risk Measures for Seattle Genetics Inc

1. Company Info - Description, identity and sector data.
2. Share Data - Stock earnings and key dates.
3. Market Risk - Beta, size, liquidity and momentum measures.
4. Financial Risk - Earnings and dividends.

by Paul Alan Davis, CFA

/ factorpad.com / stocks / f22zrd.html

SGEN Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Seattle Genetics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how SGEN stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Biological Product (except Diagnostic) Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington , is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug Conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity. The company's flagship product Adcetris is commercially available for four indications in more than 65 countries, including the U.S., Canada, Japan and members of the European Union.

Identity

• Symbol: SGEN
• FactorPad FPID: f22zrd
• SEC CIK: 0001060736
• Share Class FIGI: BBG001S9M4Q6
• Location: None, None None
• Web:

Sector and Industry

• Sector: Manufacturing
• Industry: Biological Product (except Diagnostic) Manufacturing
• SIC Code: 2836

Share Data

Shares

• Shares Outstanding: 180,895,399

Earnings and Dividends

• Trailing 12-month earnings: 2.7
• Next earnings date:

• Dividend yield in last 12 months: 0%
• Ex-dividend date:

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

• Beta: 0.69 | All: 8 | Sector: 10 | Industry: 30

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

• Market Capitalization: $31,682,020,181 | All: 13 | Sector: 15 | Industry: 17

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

• Daily Dollar Volume: $162,415,138 | All: 16 | Sector: 18 | Industry: 25

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

• Stock Price Change (1-Year): 53.28% | All: 13 | Sector: 15 | Industry: 50

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

• Earnings Yield (E/P): 1.49% | All: 61 | Sector: 57 | Industry: 34

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

• Dividend Yield (D/P): 0% | All: 83 | Sector: 78 | Industry: 59

/ factorpad.com / stocks / f22zrd.html